Men’s Health

European Commission approves AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer (mHSPC)

HealthHealthcare InnovationLatest NewsMen’s HealthOncologyPublic HealthUrology

The European Commission has approved AKEEGA® (niraparib and abiraterone acetate) for patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer, following Phase 3 data showing a significant delay in disease progression and an early survival benefit.

Read more

RCSI Study Links Social Media Use, Sexting and Body Dissatisfaction to Poor Mental Health in Irish Teenagers

Behavioural ScienceGeneralHealthHealth PsychologyLatest NewsMen’s HealthMental HealthNeurologyPsychologyPublic HealthRCSIResearchResearch & InnovationWomen’s Health

A major RCSI study surveying more than 4,000 Irish teenagers has found that heavy social media use, body dissatisfaction and engagement in sexting behaviours are strongly associated with poorer mental health and higher risk of self-harm, particularly among girls. Published in the Irish Journal of Psychological Medicine, the research offers valuable insights for national policy, education and prevention strategies.

Read more